Abstract:The discovery and advances of medicines may be considered as the ultimate relevant translational science effort that adds to human invulnerability and happiness. But advancing a fresh medication is a quite convoluted, costly, and protracted operation, normally costing USD ~2.6 billion and consuming a mean time span of 12 years. Methods to cut back expenditure and hasten new drug discovery have prompted an arduous and compelling brainstorming exercise in the pharmaceutical industry. The engagement of Artificial Intelligence (AI), including the deep-learning (DL) component in particular, has been facilitated by the employment of classified big data, in concert with strikingly reinforced computing prowess and cloud storage, across all fields. AI has energized computer-facilitated drug discovery. An unrestricted espousing of machine learning (ML), especially DL, in many scientific specialties, and the technological refinements in computing hardware and software, in concert with various aspects of the problem, sustain this progress. ML algorithms have been extensively engaged for computer-facilitated drug discovery. DL methods, such as artificial neural networks (ANNs) comprising multiple buried processing layers, have of late seen a resurgence due to their capability to power automatic attribute elicitations from the input data, coupled with their ability to obtain nonlinear input-output pertinencies. Such features of DL methods augment classical ML techniques which bank on human-contrived molecular descriptors. A major part of the early reluctance concerning utility of AI in pharmaceutical discovery has begun to melt, thereby advancing medicinal chemistry. AI, along with modern experimental technical knowledge, is anticipated to invigorate the quest for new and improved pharmaceuticals in an expeditious, economical, and increasingly compelling manner. DL-facilitated methods have just initiated kickstarting for some integral issues in drug discovery. Many technological advances, such as "message-passing paradigms", "spatial-symmetry-preserving networks", "hybrid de novo design", and other ingenious ML exemplars, will definitely come to be pervasively widespread and help dissect many of the biggest, and most intriguing inquiries. Open data allocation and model augmentation will exert a decisive hold during the progress of drug discovery employing AI. This review will address the impending utilizations of AI to refine and bolster the drug discovery operation.

Advances in machine intelligence-driven virtual screening approaches for big-data

Artificial intelligence: Machine learning approach for screening large database and drug discovery

Deep Learning in Virtual Screening: Recent Applications and Developments

Recent applications of deep learning and machine intelligence on in silico drug discovery: methods, tools and databases

A review on artificial intelligence and machine learning used in pharmaceutical research

Recent progress on the prospective application of machine learning to structure-based virtual screening

Traditional and Machine Learning Approaches in Structure-Based Drug Virtual Screening

Deep Learning and Virtual Drug Screening

Machine Learning-based Virtual Screening and Its Applications to Alzheimer's Drug Discovery: A Review.

Recent Developments in Structure-Based Virtual Screening Approaches

Evolving scenario of big data and Artificial Intelligence (AI) in drug discovery

Role of Artificial Intelligence and Machine Learning in Sustainable Drug Discovery

Artificial Intelligence and Machine Learning Technology Driven Modern Drug Discovery and Development

Machine Learning-Enabled Pipeline for Large-Scale Virtual Drug Screening

Applications of artificial intelligence to drug design and discovery in the big data era: a comprehensive review

Novel Big Data-Driven Machine Learning Models for Drug Discovery Application

Artificial intelligence and machine learning approaches for drug design: challenges and opportunities for the pharmaceutical industries

Efficient and enhanced sampling of drug‐like chemical space for virtual screening and molecular design using modern machine learning methods

Revolutionizing Drug Design with Artificial Intelligence: A Comprehensive Review of Techniques, Applications, and Case Studies

Artificial intelligence to deep learning: machine intelligence approach for drug discovery

Merging Ligand-Based and Structure-Based Methods in Drug Discovery: An Overview of Combined Virtual Screening Approaches